Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Avaxia
128 Spring Street
Suite 620
Lexington, MA 2421
Phone: 781-861-0062
www.avaxiabiologics.com

Avaxia Biologics ( www.avaxiabiologics.com ) is a development stage company developing oral antibody therapeutics that act locally within the gastrointestinal tract. The antibodies are designed to treat both diseases of the GI tract and metabolic diseases. Using its proprietary antibody platform, Avaxia is developing products for inflammatory bowel disease, GI acute radiation syndrome, celiac disease, oral mucositis, diabetes and obesity.

Key Contact
Name
Barbara Fox
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
02/14/12 $4,100,000 Series A Beacon Angels
Cherrystone Angels
Mass Medical Angels
North Country Angels
undisclosed